# Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

> **NCT00259038** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 162 (actual)

## Conditions studied

- Heart Failure, Congestive
- Heart Decompensation
- Left Ventricular Failure
- Myocardiopathies
- Systolic or Diastolic Left Ventricular Dysfunction

## Interventions

- **DRUG:** Carperitide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00259038
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2016-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259038, "Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00259038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*